重编程巨细胞与R848载荷的人造原细胞调节皮肤和骨伤口愈合
Paco López-Cuevas1, Tiah C L Oates2, Qiao Tong3
1School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, Bristol BS8 1TD, UK.
Journal of cell science
|July 30, 2024
概括
这项研究表明,R848载荷的原细胞重新编程先天性免疫细胞,特别是巨细胞,以增强伤口愈合. 这种重新编程改善了皮肤和骨的修复,并促进了受感染的伤口中的细菌清除.
科学领域:
- 免疫学 免疫学 免疫学
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 炎症细胞对于伤口修复,清除碎片和协调细胞行为至关重要.
- 调节炎症反应是改善组织损伤愈合结果的关键.
研究的目的:
- 研究使用载荷原细胞在体内对先天免疫细胞进行重新编程的可行性.
- 评估这种重编程如何影响皮肤和骨修复期间的炎症反应.
主要方法:
- 利用斑马鱼作为模型生物,因为它的透光性和遗传可处理性.
- 采用实时成像观察原细胞被巨细胞吞以及随后的细胞变化.
- 装载R848载荷的原始细胞以准Toll-like受体7和8 (TLR7/8) 信号传输.
主要成果:
- 载有R848载荷的原细胞将巨细胞重新编程为促炎性表型.
- 这种重编程改变了血管生成,原沉积和皮肤伤口愈合中的再上皮质化.
- 在骨折修复过程中观察到软化骨质细胞和骨质细胞的招募和减少骨矿化.
- 在受感染的伤口中,R848重编程的巨细胞显示出增强的杀菌活性,从而改善了愈合.
- 人类巨细胞的复制证实了类似的重编程效应.
结论:
- 用R848载荷的原细胞对先天性免疫细胞进行体内重编程,可以调节炎症反应,从而改善伤口愈合.
- 这一策略显示出在治疗伤口炎症和促进组织再生方面临床应用的潜力.
更多相关视频
08:37Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays
Published on: April 18, 2025
301
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
1.9K
相关概念视频
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K